Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of probe drugs with water, caloric drink, and grapefruit juice
NCT03012763Phase 1Completed
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Apr 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of 5-aminosalicylic acid + sulphasalazine, acetaminophen, fexofenadine and valsartan, sponsored by Universitätsklinikum Greifswald. Started Apr 2016; status: completed.
02
Drugs
5-aminosalicylic acid + sulphasalazineacetaminophenfexofenadinevalsartan
Beyond the preview
Go deeper on NCT03012763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03012763.